Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

90 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Glucose transport deficiency in diabetic animals is corrected by treatment with the oral antihyperglycemic agent pioglitazone.
Hofmann C, Lorenz K, Colca JR. Hofmann C, et al. Among authors: colca jr. Endocrinology. 1991 Oct;129(4):1915-25. doi: 10.1210/endo-129-4-1915. Endocrinology. 1991. PMID: 1915075
Lipoprotein profile characterization of the KKA(y) mouse, a rodent model of type II diabetes, before and after treatment with the insulin-sensitizing agent pioglitazone.
Castle CK, Colca JR, Melchior GW. Castle CK, et al. Among authors: colca jr. Arterioscler Thromb. 1993 Feb;13(2):302-9. doi: 10.1161/01.atv.13.2.302. Arterioscler Thromb. 1993. PMID: 8427865
Altered gene expression for tumor necrosis factor-alpha and its receptors during drug and dietary modulation of insulin resistance.
Hofmann C, Lorenz K, Braithwaite SS, Colca JR, Palazuk BJ, Hotamisligil GS, Spiegelman BM. Hofmann C, et al. Among authors: colca jr. Endocrinology. 1994 Jan;134(1):264-70. doi: 10.1210/endo.134.1.8275942. Endocrinology. 1994. PMID: 8275942
Compensatory alterations for insulin signal transduction and glucose transport in insulin-resistant diabetes.
Bonini JA, Colca JR, Dailey C, White M, Hofmann C. Bonini JA, et al. Among authors: colca jr. Am J Physiol. 1995 Oct;269(4 Pt 1):E759-65. doi: 10.1152/ajpendo.1995.269.4.E759. Am J Physiol. 1995. PMID: 7485492
Reduced expression of hexokinase II in insulin-resistant diabetes.
Braithwaite SS, Palazuk B, Colca JR, Edwards CW 3rd, Hofmann C. Braithwaite SS, et al. Among authors: colca jr. Diabetes. 1995 Jan;44(1):43-8. doi: 10.2337/diab.44.1.43. Diabetes. 1995. PMID: 7813813
Malonyl coenzyme A and adiposity in the Dahl salt-sensitive rat: effects of pioglitazone.
Kurowski TG, Saha AK, Cunningham BA, Holbert RI, Colca JR, Corkey BE, Ruderman NB. Kurowski TG, et al. Among authors: colca jr. Metabolism. 1996 Apr;45(4):519-25. doi: 10.1016/s0026-0495(96)90230-9. Metabolism. 1996. PMID: 8609842
Lipid abnormalities in tissues of the KKAy mouse: effects of pioglitazone on malonyl-CoA and diacylglycerol.
Saha AK, Kurowski TG, Colca JR, Ruderman NB. Saha AK, et al. Among authors: colca jr. Am J Physiol. 1994 Jul;267(1 Pt 1):E95-101. doi: 10.1152/ajpendo.1994.267.1.E95. Am J Physiol. 1994. PMID: 8048519
Pioglitazone inhibits the diabetogenic action of growth hormone, but not its ability to promote growth.
Towns R, Kostyo JL, Colca JR. Towns R, et al. Among authors: colca jr. Endocrinology. 1994 Feb;134(2):608-13. doi: 10.1210/endo.134.2.8299559. Endocrinology. 1994. PMID: 8299559
Synthesis and biological activity of metabolites of the antidiabetic, antihyperglycemic agent pioglitazone.
Tanis SP, Parker TT, Colca JR, Fisher RM, Kletzein RF. Tanis SP, et al. Among authors: colca jr. J Med Chem. 1996 Dec 20;39(26):5053-63. doi: 10.1021/jm9605694. J Med Chem. 1996. PMID: 8978836
Insulin sensitization in diabetic rat liver by an antihyperglycemic agent.
Hofmann C, Lorenz K, Williams D, Palazuk BJ, Colca JR. Hofmann C, et al. Among authors: colca jr. Metabolism. 1995 Mar;44(3):384-9. doi: 10.1016/0026-0495(95)90171-x. Metabolism. 1995. PMID: 7885286
90 results
Jump to page
Feedback